Neutrophils and platelets are frequently present in glomeruli in immune glomerulonephritis (GN). No role for the platelet in acute neutrophil-mediated renal injury has been defined. We investigated a neutrophil-mediated model of subendothelial immune complex GN in the rat. Rats were platelet-depleted (mean platelet < 10,000/1A) with goat anti-platelet IgG before induction of GN by the renal artery perfusion of concanavalin A followed by anti-concanavalin A IgG. Platelet-depletion resulted in a significant reduction in albuminuria (7±2 vs. 55±10 mg/24 h) and fractional albumin excretion (0.045±0.01 vs. 0.410±0.09) compared with controls. The decrease in albuminuria was not due to differences in blood or glomerular neutrophil counts, complement, renal function, or glomerular antibody binding. Platelet-depleted rats had equivalent subendothelial deposits and glomerular endothelial cell injury but had minimal platelet infiltrates and fibrin deposition compared with controls. These studies demonstrate a role for platelets in mediating acute neutrophil-induced glomerular injury and proteinuria in this model of GN.
Introduction
Neutrophils and platelets are the dominant inflammatory cells at sites of injury in the initial phase of various immunologically mediated diseases, including the Arthus and Shwartzman reaction, hyperacute transplant rejection and some forms of passive cutaneous anaphylaxis (1) (2) (3) . Although studies performed in the Arthus reaction suggest that it is neutrophil mediated but platelet independent (4, 5), most of these diseases appear to be mediated by both neutrophils and platelets (1, 3, (6) (7) (8) . In addition, platelet depletion has been reported to reduce neutrophil-mediated lung injury in both the mouse and rat after systemic complement activation (9, 10) .
Neutrophils and platelets or their antigens have also been demonstrated in association with each other in various animal and human glomerular diseases (1 1-13). The coexistence of neutrophils and platelets has been particularly noted in systemic lupus erythematosus (SLE) with subendothelial immune complex (IC)' deposits (12, 13) . Despite the presence of both 1. Abbreviations used in this paper: Anti-Con A, rabbit anti-concanavalin A IgG; APS, goat anti-rat platelet IgG; Cc,,at, creatinine clearance; neutrophils and platelets in this disease, the role of platelets in mediating SLE and other types of glomerulonephritis (GN) has not been well studied.
Our interest in neutrophil-platelet interactions was initiated by our observations of the glomerular injury that results from one of the major cytotoxic mechanisms of the neutrophil, i.e., the myeloperoxidase (MPO)-hydrogen peroxide (H202)-halide system (14). When the renal artery of rats is perfused with the neutrophil enzyme MPO and its substrates H202 and chloride, severe glomerular endothelial cell injury and proteinuria results, and this is associated with marked platelet infiltration and activation (14, 15) .
We have also studied a model of immune complex nephritis in the rat that is neutrophil mediated and associated with subendothelial deposits (16) , thus resembling diffuse proliferative lupus nephritis or type I membranoprolifer4tive GN in man. In this model as well, evidence for participation ofthe MPO-H202-halide system has been provided and platelets can be frequently demonstrated within glomeruli and adherent to deposits (16) .
We now report on the effects of platelet depletion in this neutrophil-dependent model of subendothelial immune complex nephritis. The evidence presented here demonstrates a critical requirement for platelets for the development of acute glomerular injury.
Methods
Description ofimmune complex GN model. Immune complex GN was induced in rats by the selective renal artery perfusion of concanavalin A (Con A) followed by anti-concanavalin A (anti-Con A) antibody (16) . This is a modification ofthe model originally described by Golbus and Wilson (17) , and is based on the ability ofthe lectin Con A to bind to glycoproteins present in the glomerular capillary wall and hence function as a "planted" antigen. The subsequent perfusion ofanti-Con teric arteries, which lie opposite each other on the aorta. Renal artery blood flow was then interrupted by clamping the aorta at these locations, and the kidney was perfused by cannulating the superior mesenteric or left renal artery in a retrograde manner using a 30-gauge needle, with the aid of a dissecting microscope (Reichert Scientific Instruments, Buffalo, NY).
All perfusions consisted initially of 0.5 ml of PBS, pH 7.2, to displace any blood remaining in the kidney. The kidney was then perfused with 1.0 ml of PBS containing 125 ,gg Con A (ICN Biomedicals, Costa Mesa, CA) that was determined using an extinction coefficient (E'%) of 12.8 for Con A. After the Con A perfusion, the cannula was cleared with 0.2 ml PBS, and then 19 mg of anti-Con A IgG in 0.5 ml PBS was infused, followed by 0.2-0.3 ml PBS. All perfusions were performed using a constant infusion pump (Sage Instruments Division, Orion Research Inc., Cambridge, MA) at a rate of0.5 ml/min on a heated operating table. After the perfusion the aorta was unclamped and blood flow was immediately restored to the kidney. Total ischemia time was always < 8 min. The needle was then removed and the bleeding was stopped by applying gelfoam (Upjohn Co., Kalamazoo, MI) and/or cyanoacrylate adhesive (Borden Inc., Columbus, OH). In some platelet-depleted rats bleeding was difficult to stop, and these animals were excluded from analysis. In the remainder of the animals (both platelet depleted and control), hemostasis could be adequately achieved with total blood loss generally < 2 ml. The abdominal wound was then closed and the rat was placed under a heat lamp for 1-2 h.
Experimental design. Two groups of 14 rats were studied. One group was platelet-depleted before induction of immune complex GN. This was accomplished by administering between 40 and 50 mg ofgoat anti-rat platelet IgG (APS) per 100 g body wt i.p. 14 to 21 h before surgery and induction of GN. This dose of APS resulted in severe thrombocytopenia (mean platelet count < 10,000/Ml blood) within 8 h of administration and maintained mean platelet counts < 10,000/,gl for a 24-h period after the induction ofGN. The control group received equivalent doses of normal goat IgG within the same time period before renal artery perfusions.
Blood samples were collected from the tail vein before injection of APS or normal goat IgG (pre) and again immediately before surgery at the time of disease induction (t = 0). After surgery rats were housed in metabolic cages with free access to water and the urine was collected overnight (14-20 h). A blood sample was then obtained via a cardiac puncture, the kidney was biopsied for histologic studies, and the rat was killed by ether inhalation. In some rats quantitative glomerular antibody binding studies were performed as outlined below.
Preparation of anti-Con A antibody. New Zealand white rabbits (R & R, Stanwood, Washington) were immunized with Con A as previously described ( 16 Because the administration of APS intravenous has been reported to cause significant hemodynamic impairment (19) we injected APS intraperitoneally. Six rats injected intraperitoneally with APS had systolic blood pressures measured before APS injection and at 2, 6, and 24 h later. Blood pressure was measured after induction of light anesthesia with ether using a tail cuff connected to a pressure transducer and recorded with a plethysmograph (Narco Biosystems, Houston, TX). Blood pressure in these rats remained unchanged at all times studied with the mean systolic BP always in excess of 100 mmHg.
Studies performed in vitro demonstrated that APS reacted against normal rat serum with a titer of 1:2 on microouchterlony plates. APS also caused agglutination of erythrocytes at a titer of 1:20 but did not result in discernible hemolysis when injected into normal animals. APS was also tested for its ability to band rat PMNs and macrophages. Rat PMNs were collected from the peritoneal cavity of normal rats 3-4 h after i.p. injection with 0.1% oyster glycogen (Sigma Chemical Co., St. Louis, MO) and were > 95% pure as assessed by Wright's stain. Rat macrophages were harvested from peritoneal exudate 4 d after the injection of 3% thioglycollate i.p. (Difco) (20) . The macrophages were grown overnight in RPMI with 10% fetal calfserum and 15 mM Hepes buffer (Gibco Laboratories, Santa Clara, CA), and were > 95% pure as assessed by the uptake of neutral red. Rat platelets (5 X 107/well), PMNs ( 105/well) and macrophages ( 105/well) were added to poly-L-lysine (Sigma Chemical Co.) coated 96-well plates (Nunc, Roskilde, Denmark). The cells were blocked with 2% BSA (Sigma Chemical Co.) and fixed with 2% paraformaldehyde. They were then blocked with 2% BSA, 0.1 M glycine in PBS, 3% H202 in cold methanol, and normal rabbit IgG (Calbiochem-Behring Corp., San Diego, CA). After washing with PBS, the cells were incubated with various dilutions of APS or normal goat IgG. After extensive washing the presence ofgoat IgG was determined using a biotinylated rabbit anti-goat IgG (Vector Laboratories, Burlingame, CA) followed by avidin peroxidase (ABC Kit, Vector Laboratories), and developed with O-phenylene-diamine (Sigma Chemical Co.). The reaction was stopped after 5 min with 4.5 M H2SO4 and was read at 492 nm. All measurements were done in quadruplicate. Rat platelets reacted strongly with APS, and a dilution of 1:20,000 (i.e., 3.7 gg/ml) had slightly greater reactivity than 1:500 dilution of normal goat IgG (i.e., 130 ,g/ml). In contrast, rat PMNs and macrophages reacted no stronger with APS than normal goat IgG.
Measurements. Platelet counts were determined by phase microscopy after lysis of erythrocytes with 1% ammonium oxalate. Hematocrit and white cell counts were determined by standard hematologic techniques, and white cell differentials were determined from blood smears stained with Diff-Quik (American Scientific Products, McGaw Park, IL). Plasma samples were assayed for creatinine using the picric acid method (Worthington Diagnostics, Freehold, NJ). Plasma albumin was measured with bromcresol green using an autoanalyzer (21) . Plasma C3 levels were measured by radial immunodiffusion (22) and quantitated in each rat as a percentage ofits baseline (i.e., pre) C3 level. The titer of heparinized plasma that results in lysis of 50% of sheep erythrocytes that are coated with rabbit anti-sheep erythrocyte IgG (Diamedix, Miami, FL) (CH50) was measured using standard methodology (23) . Urine total protein was measured using the sulfosalicylic acid method (24). Urine albumin was measured in 96-well microtiter plates (Dynatech, Alexandria, VA) by an ELISA method using a sheep anti-rat albumin (0.3 ug/well) (Organon Teknika Corp., BCA Cappel, West Chester, PA) as the coating antibody and a peroxidase-labeled sheep anti-rat albumin (2 gg/well; Organon Teknika Corp.) as the detecting antibody (20) . The presence of detecting antibody was determined after incubation with 0.2 mM 2,2'-azino-di-(3-ethylbenzthiazoline-sulfonate) (ABTS) (Boehringer Mannheim, Indianapolis, IN) and 2.5 mM H202 in 100 mM acetate buffer at pH 5.0, and was measured spectrophotometrically at 405 nm, using a Dynatech MR 560 microplate reader (Dynatech). The ELISA method was standardized using samples that had also been assayed for albumin using the autoanalyzer method.
Glomerular antibody binding of anti-Con A. To insure that glomerular binding of anti-Con A antibody was not altered by platelet depletion, glomerular antibody binding of anti-Con A was determined using a double-label method (25) . Briefly, control rats or platelet-depleted rats had GN induced as described above except that the antiCon A was trace-labeled with '25I by the chloramine T method (26) . Rats were then placed in metabolic cages for urine collection for a mean of 15 to 16 h. 1 h before sacrifice rats received 10 gg '31I-rat IgG as a blood marker. At sacrifice the kidney was removed, and glomeruli were isolated from the cortex using differential sieving techniques (26) . Glomeruli were counted visually with a Fuchs-Rosenthal counting chamber (Hausser-Scientific Co., Blue Bell, PA) and specific glomerular deposition of 1251I IgG determined using a Prias autogamma counter (Packard Instrument Co., Downers Grove, IL) as described elsewhere (26) . Briefly, the specific glomerular uptake of 1251-anti-Con A was calculated using the formula: Specific glomerular '251I-anti-Con A up-
, where G 1251 and G 131I are counts per LB1311 minute of 1251I and '1'I in an aliquot of glomeruli and B 125I and B 13'I are counts per minute of 1251 and 13'I in 1 ml of whole blood (26) . Counts per minute of 251-anti-Con A were converted to gg total antiCon A antibody per 38,000 glomeruli (the average number of glomeruli present in a rat kidney [27] ) based on the specific activity of 1251I anti-Con A preparations.
Renal histology. Tissue for light microscopy was initially fixed in Sorensen's buffered formalin (10% formalin in 0.1 M Na phosphate buffer, pH 7.2) for at least 4 h, and was then dehydrated in graded ethanols and embedded in glycomethylmethacrylate (Polysciences, Warrington, PA) (15). 2-,gm sections were stained with periodic acid Schiff reagent.
The number of neutrophils present per glomerular cross-section was counted by two observers without knowledge of whether the biopsy was from a platelet-depleted or control rat. 10 glomeruli were examined per rat, and the average number of neutrophils per glomerulus was calculated. Glomerular cross-sections containing only a minor portion of the glomerular tuft (< 20 discrete capillary segments per cross-section) were not utilized in obtaining neutrophil counts.
Tissue for immunofluorescence (IF) was embedded in O.C.T. (Lab-Tek Products, Miles Laboratories, Naperville, IL) and snap-frozen in isopentane (28) . Con A was detected by indirect IF using a biotinylated goat anti-Con A antibody followed by FITC-conjugated strep-avidin (Amersham, Arlington Heights, IL). Rabbit anti-Con A IgG was detected using FITC-conjugated goat anti-rabbit IgG, rat C3 with FITC-conjugated goat anti-rat C3, and rat fibrin with FITC-conjugated goat anti-rat fibrinogen. The presence of rat C5b-9 was determined using a biotinylated mouse antirat C5b-9 monoclonal antibody that had been previously prepared in our laboratory,2 followed by FITC-strep-avidin. Sections were examined with a Leitz Ortholux II microscope with a Ploempak 2.2 vertical fluorescence illuminator (E. Leitz, Inc., Rockleigh, NJ). The intensity of fluorescence was graded semiquantitatively from 0 to 4+ as described previously (28) . In evaluating fibrin deposition the following scale was used: 0, fibrin deposition absent; 1+, up (29) .
Results
Induction ofthrombocytopenia with APS. The administration of APS resulted in severe thrombocytopenia (mean platelet < 10,00041d) that was maintained from the time of induction of immune complex GN until the time of sacrifice 24 h later (Table I ). Control rats also had a substantial fall in their platelet counts (-60%) after induction of GN, possibly reflecting platelet consumption secondary to the disease process (Table I).
Both control and APS-treated rats developed a mild neutrophilia after injection with IgG or APS, respectively. However, there were no differences in neutrophil counts between groups. Platelet-depleted rats did have a slightly higher total white cell count at sacrifice (P < 0.02; Table I ).
Hematocrit levels fell in the platelet-depleted rats from the time of surgery and disease induction until sacrifice (P < 0.001). The fall in hematocrit was primarily due to slow and persistent bleeding during the postoperative period in plateletdepleted animals.
Effect ofplatelet-depletion on glomerular antibody binding. that glomerular deposition of antibody was equivalent in the control and platelet-depleted groups.
Effect ofplatelet-depletion on histology. Control rats with immune complex GN (n = 14) developed a severe proliferative nephritis with prominent neutrophil and mononuclear cell infiltration at 24 h (Fig. 1) . Most glomeruli have significant intracapillary thrombus formation, and occasional segmental necrosis of capillary loops. Platelet-depleted rats had more infiltrating neutrophils in glomeruli than control rats at 24 h (7.6±0.9 PMNs/glomerular cross-section vs. 3.5±0.5 PMNs/glomerulus, P < 0.001). Platelet depletion was also associated with a dramatic diminution of intracapillary thrombi and segmental necrosis (Fig. 1) . The reduction in glomerular thrombosis in platelet depleted rats may have allowed increased access of neutrophils to capillary lumina accounting for the higher glomerular neutrophil counts in APS-treated animals. The presence of clots in the capillary lumina in control rats also resulted in considerable cell compression and distortion of intraluminal cells, which made identification of neutrophils more difficult.
IF showed that there appeared to be no differences in platelet-depleted and control rats with immune complex GN in glomerular deposits of Con A antigen, rabbit IgG, rat C3, and rat C5b-9 at 24 h after disease induction. Staining for Con A antigen was 2-3+, rabbit IgG 3-4+, rat C3 2-3+, and rat COb-9 was trace to 1+. However, there were differences noted in fibrin deposition. Control rats had fibrin deposition in 50 to 75% of most capillary loops, whereas platelet-depleted rats had minimal (< 25%) fibrin deposition (Fig. 2) .
Electron microscopy of glomeruli from control rats with immune complex GN demonstrated a dense band of subendothelial deposits associated with endothelial cell denudation and focal epithelial cell foot process fusion (Fig. 3 A) . Subepithelial deposits were present focally. Platelets and neutrophils could frequently be demonstrated adherent to the subendothelial deposits, and fibrin and platelet aggregates were present within capillary loops (Figs. 3 and 4) . Rats that were plateletdepleted also had subendothelial and focal subepithelial deposits associated with endothelial cell injury and neutrophil infiltration (Fig. 5) . However, there was a marked reduction in platelet infiltration and fibrin deposition, and only minimal epithelial cell foot process fusion. Animals in both groups showed ultrastructural evidence of neutrophil activation, characterized by pseudopodia formation, degranulation and the presence of intracytoplasmic phagocytic vacuoles. Neutrophils in platelet-depleted rats appeared to have more extensive degranulation, but there was considerable overlap in this parameter between the two groups, and even within neutrophils present in individual animals in each group.
Effect ofplatelet-depletion on urine protein excretion and renal function. Platelet-depleted rats with immune complex GN had significantly lower total urine albumin excretion in the first 24 h after disease induction than control rats (6.8±1.7 vs. 54.6±10.0 mg/d, Table II, P < 0.001). In four platelet-depleted rats protein excretion was also quantitated on days 1-2. Two rats that maintained platelet counts of < 15,000/,l through days 1-2 continued to excrete < 20 mg of protein, whereas two rats that had been adequately platelet depleted on days 0-1 but whose platelet counts had risen to 100,000 and 122,000/,gl on days 1-2 had protein excretions of 107 and 133 mg/d, respectively. These latter results are similar to the 112±10 mg/d of proteinuria that we had previously reported for days 1-2 in control rats with Con A anti-Con A GN (16) .
To exclude an effect of glomerular filtration rate or serum albumin concentration on urinary albumin excretion in the platelet-depleted and control rats with GN, fractional excretion of albumin (FE.1b) was measured. As shown in Table II , FEalb was significantly lower in platelet-depleted rats with Con A anti-Con A GN (P < 0.001). In contrast, no differences in creatinine clearances (C,,) or serum creatinines were noted in APS-treated and control rats. Urine volumes, however, were greater in platelet-depleted versus control rats (P < 0.02, To exclude an effect of anemia on lowering the protein excretion (30) in the platelet-depleted rats, we induced immune complex GN in five additional rats that had been previously made anemic by repeated cardiac punctures. Despite having similar hematocrits as the platelet-depleted rats 24 h after induction of GN (26±1 vs. 26±1, P = NS), the total protein excretion in the anemic control rats was significantly greater than in the platelet-depleted rats (93±23 mg/d vs. 15±2 mg/d, P < 0.00 1).
Effect of platelet-depletion on plasma complement levels.
The injection of APS and normal goat IgG intraperitoneally resulted in a decrease in CH50 levels that was noted at the time of induction of GN (Table III) . Both CH50 and C3 levels were lower in platelet-depleted rats at the time of renal artery perfusion and induction of GN than in control rats (P < 0.00 1) but differences between the groups did not persist at 24 h. To exclude the possibility that the decrease in urine albumin excretion was secondary to this transient reduction in complement levels, a separate analysis was performed on a subset of rats from the control and platelet-depleted groups that had equivalent complement levels. When all rats that had CH50 titers between 20 and 29 at the time of GN induction were analyzed, there remained a marked difference in albumin excretion (7±3 mg albumin/24 h in APS-treated rats (n = 6) vs. 76±14 mg albumin/24 h in control rats (n = 7), P < 0.01 by Wilcoxon-rank sum test). Similarly, if rats with C3 levels between 75 and 95% at the time of surgery were analyzed, a difference in protein excretion between platelet-depleted and control rats was again noted [7±2 mg/24 h in APS-treated rats (n = 5) vs. 70±25 mg/24 h in controls (n = 4), P < 0.051. Finally, there was no correlation between complement levels and urine albumin excretion in individual animals in plateletdepleted and control groups. Therefore, the depression of complement observed in the platelet-depleted rats appears not to have contributed to the observed difference in urine albumin excretion.
Discussion
We have been studying an immune complex model ofglomerulonephritis in the rat induced by the renal artery perfusion of Con A antigen and anti-Con A antibody. The model is characterized by a diffuse proliferative nephritis associated with neutrophil and platelet infiltration, marked fibrin deposition, and subendothelial immune complex deposits. Similar glomerular lesions are seen in severe lupus nephritis and type I membranoproliferative glomerulonephritis in man. Previous studies have demonstrated that depletion of neutrophils to < 250/ mm3 with antineutrophil serum significantly reduced the proteinuria and abolished the glomerular neutrophil infiltrate associated with this model (16) . The role of platelets, which are so frequently associated with neutrophils in this model, has not been studied. This study addressed the question ofwhether these platelets participated in mediating the acute phase of neutrophil-induced immune injury or were simply present as a secondary response to tissue damage.
The findings reported here demonstrate that platelets are required for neutrophil-mediated injury to occur in this model. Specifically, selective depletion of platelets in the rat to < 10,000/h abolished proteinuria, improved glomerular histology and markedly diminished fibrin deposition. These effects were independent of the amount of glomerular antibody bound and of alterations in plasma complement levels. Moreover, they could not be explained by any effect of antiplatelet IgG on circulating leukocytes or neutrophil counts. We have also been able to show that the antiplatelet IgG does not affect PMN function, as assessed by the ability ofrat PMNs to release hydroxyproline from rat GBM containing aggregated IgG or to iodinate protein in the presence of opsonized zymosan (data not shown). Despite a reduction in proteinuria, platelet-depleted rats had even greater numbers of neutrophils observed by light microscopy within glomeruli than control rats with immune complex GN. This was probably due to the lack of intraglomerular thrombi in the platelet-depleted rats, thereby providing greater accessibility of neutrophils to the capillary lumina. However, this would have been expected to result in greater injury in the platelet-depleted rats if neutrophils were the only cellular mediators of glomerular damage.
The possibility that hemodynamic alterations induced by platelet depletion might have contributed to the decreased protein excretion observed was considered. Platelet-depleted rats had more blood loss after surgery than did controls. However, the fractional excretion of albumin was also reduced in platelet-depleted rats as compared to controls, and this corrects for differences in serum albumin and glomerular filtration rate (31). The urine volume was actually higher in the platelet-depleted rats, which further suggests that the blood loss did not result in significant volume depletion. Anemia has also been reported to decrease glomerular pressures and reduce proteinuria (30 (35, 36) , as well as in membranoproliferative and mesangial proliferative GN in man (37, 38) . However, previous studies of selective platelet depletion in experimental models of glomerular disease have not consistently confirmed a role for the platelet in mediating immune renal injury. In the neutrophil-independent model of acute serum sickness in rabbits platelet depletion had no effect in one study (19) , whereas in another study platelet depletion resulted in decreased immune complex localization in glomeruli (39) . Platelet depletion has also been reported to have no effect on the autologous phase of nephrotoxic nephritis in the rabbit (40) , although another study reported that platelet depletion resulted in lower protein excretion for the first 3 d in the accelerated version ofthis same model (41) . A likely explanation for why these prior studies have been inconclusive is that the models studied are not characterized by extensive neutrophil or platelet involvement as seen in the present model of immune complex GN. Studies by others have shown that the glomerular inflammatory reaction induced by immune deposits is dependent on the site as well as the mechanism of glomerular immune deposit formation with substantially more inflammatory cell involvement if immune deposits are formed adjacent to the capillary lumen as in the model studied here as opposed to deposit formation in an intramembranous or subepithelial location (42).
The mechanisms by which platelets localize in glomeruli in subendothelial immune complex nephritis have not been defined. Endothelial cell injury secondary to neutrophil or complement action could result in the release of platelet activating factor (PAF) (43) . Neutrophils and mesangial cells can also produce PAF (reviewed in 44). Once the endothelium has been denuded, platelets could adhere to the subendothelial microfibrils and the collagen-rich glomerular basement membrane (GBM) (45) . Platelets can also adhere to accessible immune complexes in the rat, perhaps via a C3b receptor mechanism (46) .
The mechanism for the platelet-mediated increase in glomerular permeability observed in our studies was not defined in the experiments reported here. Two possibilities exist that cannot be readily differentiated by our findings. One is that platelets themselves may act as inflammatory effector cells in certain circumstances. Thus platelets can release cationic proteins that will bind to GBM and neutralize the anionic charge barrier (reviewed in 47). Platelets also contain proteolytic enzymes including elastase, cathepsins, and collagenase (47) that potentially might degrade GBM through mechanisms similar to those that have been defined in the neutrophil. Platelets also release vasoactive amines, PAF, and thromboxane (TXA2); all ofthese substances have been shown or proposed to participate in various forms ofglomerular disease (36, 39, 48, 49) . Indeed, perfusion of the renal artery of rabbits with PAF results in a mild increase in protein excretion (50) . Finally, studies have demonstrated that mouse platelets are cytotoxic to antibody and C3b-coated sheep erythrocytes through a mechanism that has not been defined (51) . However, the hypothesis that the platelet is an inflammatory effector cell does not provide a ready explanation for why tissue injury in this model is equally well prevented by neutrophil depletion ( 15) .
An alternative hypothesis is that platelets are not themselves effector cells but may play an essential role in facilitating the action of neutrophils in mediating glomerular injury. Several observations support this mechanism as a more likely explanation of our findings. Thus, platelets produce various chemotactic substances that can increase neutrophil adherence to damaged endothelial cells, as well as increase neutrophil aggregation, phagocytosis and release of reactive oxygen species and MPO (52) (53) (54) (55) . The platelet factors responsible for these actions are diverse, but include PAF, TXA2, PF4, and platelet derived growth factor (PDGF) (44, [54] [55] . Platelet factor 4 can also potentiate neutrophil elastase action (59) . It is noteworthy that pulmonary microvascular injury induced by systemic complement activation is mediated by neutrophils through release of toxic oxygen products (60), and that this lesion can be markedly attenuated by prior depletion of platelets (9, 10) . Moreover, the release of O°by rat neutrophils is substantially enhanced by rat platelets, perhaps through platelet release of ATP and/or ADP (55) . We have previously provided evidence that reactive oxygen species may participate in producing neutrophil mediated glomerular injury in the model of subendothelial immune complex nephritis studied here via the MPO-H202-halide system ( 16) . Thus, our observation that platelet depletion results in a reduction in protein and fibrin deposition in this neutrophil-mediated model is consistent with the hypothesis that platelets enhance neutrophil-induced glomerular oxidant injury through similar mechanisms.
Our studies also demonstrated that platelets were required for fibrin deposition in this model. Most animal studies of GN have suggested that tissue factor, released by monocytes, is the major stimulus for fibrin deposition (61) . Platelets can also increase tissue factor release from endothelial cells in the presence of aggregated IgG (62). Platelets also contain phospholipids that can activate the intrinsic pathway by both Factor XII-dependent and Factor XII-independent pathways (63) as well as directly facilitating Factor Va expression, Factor X activation and prothrombin consumption (reviewed in 64).
In conclusion, we have described a previously unrecognized requirement for platelets in a neutrophil-mediated model of immune complex injury. The mechanism of the augmentation of injury by platelets is unclear but may be critical to many forms of neutrophil-induced tissue injury. The possibility that this interaction exists in human glomerular disease, such as that seen in SLE, remains to be explored.
